Generic Drugs/Biosimilars

Dec 02, 2002
Pharmaceutical Technology
Reform legislation about generic drugs remains at the forefront of debate as innovator companies poise to challenge FDA proposals regarding patent laws.
native1_300x100
lorem ipsum